'Fast-track' drug approvals hit speed bumps in Japan.
Sipp
Douglas
D
D017277:Drug Approval / Q000331:legislation & jurisprudence* / Q000379:methods*; D004341:Drug Evaluation / Q000331:legislation & jurisprudence*; D000077156:Gefitinib; D007555:Isoxazoles / Q000009:adverse effects; D007564:Japan; D000077339:Leflunomide; D011640:Public Policy; D011799:Quinazolines / Q000009:adverse effects
D007555:Isoxazoles; D011799:Quinazolines; D000077339:Leflunomide; D000077156:Gefitinib